Mechanisms of disease: HDL metabolism as a target for novel therapies

Area of Science:

• Cardiovascular Medicine
• Metabolic Research
• Pharmacology

Background:

• Plasma high-density lipoprotein (HDL) cholesterol levels are inversely correlated with coronary heart disease (CHD) risk.
• Low HDL-cholesterol is a risk factor for CHD, even with aggressive low-density lipoprotein (LDL) reduction.
• Existing therapies have limited efficacy in raising HDL-cholesterol levels.

Purpose of the Study:

• To review the current status of novel therapies targeting HDL metabolism.
• To explore new therapeutic strategies for raising HDL-cholesterol or improving HDL function.

Main Methods:

• Review of recent developments in HDL metabolism research.
• Analysis of novel therapeutic approaches targeting HDL.

Main Results:

• Current therapeutic approaches to increase HDL-cholesterol are limited.
• Significant focus on developing novel therapies to modulate HDL levels or function.

Conclusions:

• There is a critical need for novel therapies to address low HDL-cholesterol levels.
• Therapeutic strategies are being developed to either increase HDL-cholesterol or enhance its cardioprotective functions.